As another example of inflammation-modulatory properties, Liu et al. developed a transformable peptide nanoplatform (BP-FFVLK-DSGLDSM, BFD) designed to treat rheumatoid arthritis (RA) by targeting the NF-κB/IκBα signaling pathway. Here, NFKBIA is linked to rheumatoid arthritis.